ID

36881

Description

Focal Prostate Radio-Frequency Ablation; ODM derived from: https://clinicaltrials.gov/show/NCT02328807

Lien

https://clinicaltrials.gov/show/NCT02328807

Mots-clés

Versions (1)
  1. 18/06/2019 18/06/2019 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

18 juin 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Prostate Cancer NCT02328807

Anglais

Eligibility Prostate Cancer NCT02328807

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
men 18 years of age or older
Description

Gender | Age

Type de données

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
diagnosis of adenocarcinoma of the prostate, confirmed by h.l. moffitt cancer center review
Description

Adenocarcinoma of prostate

Type de données

boolean

Alias
UMLS CUI [1]
C0007112
no prior treatment for prostate cancer
Description

Prostate carcinoma Untreated

Type de données

boolean

Alias
UMLS CUI [1,1]
C0600139
UMLS CUI [1,2]
C0332155
eastern cooperative oncology group (ecog) performance status of 0 or1
Description

ECOG performance status

Type de données

boolean

Alias
UMLS CUI [1]
C1520224
prostate cancer clinical stage t2a and below
Description

Prostate carcinoma TNM clinical staging

Type de données

boolean

Alias
UMLS CUI [1,1]
C0600139
UMLS CUI [1,2]
C3258246
psa <10 ng/ml (this will be the prostatic specific antigen (psa) level prompting the initial prostate biopsy)
Description

Prostate specific antigen measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0201544
prostate size <60 cc on transrectal ultrasound
Description

Size of prostate TRUS

Type de données

boolean

Alias
UMLS CUI [1,1]
C1287816
UMLS CUI [1,2]
C0373345
pre-enrollment biopsy parameters (as per h.l. moffitt c.c. review): minimum of 10 biopsy cores; no primary pattern biopsy gleason grade 4 or 5; unilateral cancer (only right-sided or left-sided, not bilateral); no more than 1 core with 50% cancer; no more than 4 cores with positive biopsies with gleason pattern 3 + 3 and no more than 2 cores with positive biopsies containing gleason pattern 3 + 4.
Description

Biopsy Parameters | Status pre- Enrollment | Core biopsy Quantity Minimum | Primary Gleason pattern | Neoplasm Unilateral | Neoplasm Percentage Core biopsy | Core biopsy Positive Quantity Gleason pattern

Type de données

boolean

Alias
UMLS CUI [1,1]
C0005558
UMLS CUI [1,2]
C0449381
UMLS CUI [2,1]
C0332152
UMLS CUI [2,2]
C1516879
UMLS CUI [3,1]
C1318309
UMLS CUI [3,2]
C1265611
UMLS CUI [3,3]
C1524031
UMLS CUI [4]
C1273604
UMLS CUI [5,1]
C0027651
UMLS CUI [5,2]
C0205092
UMLS CUI [6,1]
C0027651
UMLS CUI [6,2]
C0439165
UMLS CUI [6,3]
C1318309
UMLS CUI [7,1]
C1318309
UMLS CUI [7,2]
C1514241
UMLS CUI [7,3]
C1265611
UMLS CUI [7,4]
C1273606
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
men less than 18 years of age
Description

Gender | Age

Type de données

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
medically unfit for anesthesia
Description

Medically unfit Anesthesia

Type de données

boolean

Alias
UMLS CUI [1,1]
C3841806
UMLS CUI [1,2]
C0002903
histology other than adenocarcinoma
Description

Histology | Exception Adenocarcinoma

Type de données

boolean

Alias
UMLS CUI [1]
C0344441
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0001418
biopsy does not meet inclusion criteria
Description

Biopsy Inclusion criteria failed

Type de données

boolean

Alias
UMLS CUI [1,1]
C0005558
UMLS CUI [1,2]
C1512693
UMLS CUI [1,3]
C0231175
men who have received any hormonal manipulation (antiandrogens; luteinizing hormone releasing hormone (lhrh) agonist; 5-alpha-reductase inhibitors) within the previous 6 months
Description

Gender Hormone manipulation | Androgen Antagonists | LHRH Agonist | 5-alpha Reductase Inhibitors

Type de données

boolean

Alias
UMLS CUI [1,1]
C0079399
UMLS CUI [1,2]
C0586971
UMLS CUI [2]
C0002842
UMLS CUI [3]
C1518041
UMLS CUI [4]
C2936788
Retour au début de la page

Similar models

Eligibility Prostate Cancer NCT02328807

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Gender | Age
Item
men 18 years of age or older
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Adenocarcinoma of prostate
Item
diagnosis of adenocarcinoma of the prostate, confirmed by h.l. moffitt cancer center review
boolean
C0007112 (UMLS CUI [1])
Prostate carcinoma Untreated
Item
no prior treatment for prostate cancer
boolean
C0600139 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status of 0 or1
boolean
C1520224 (UMLS CUI [1])
Prostate carcinoma TNM clinical staging
Item
prostate cancer clinical stage t2a and below
boolean
C0600139 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
Prostate specific antigen measurement
Item
psa <10 ng/ml (this will be the prostatic specific antigen (psa) level prompting the initial prostate biopsy)
boolean
C0201544 (UMLS CUI [1])
Size of prostate TRUS
Item
prostate size <60 cc on transrectal ultrasound
boolean
C1287816 (UMLS CUI [1,1])
C0373345 (UMLS CUI [1,2])
Biopsy Parameters | Status pre- Enrollment | Core biopsy Quantity Minimum | Primary Gleason pattern | Neoplasm Unilateral | Neoplasm Percentage Core biopsy | Core biopsy Positive Quantity Gleason pattern
Item
pre-enrollment biopsy parameters (as per h.l. moffitt c.c. review): minimum of 10 biopsy cores; no primary pattern biopsy gleason grade 4 or 5; unilateral cancer (only right-sided or left-sided, not bilateral); no more than 1 core with 50% cancer; no more than 4 cores with positive biopsies with gleason pattern 3 + 3 and no more than 2 cores with positive biopsies containing gleason pattern 3 + 4.
boolean
C0005558 (UMLS CUI [1,1])
C0449381 (UMLS CUI [1,2])
C0332152 (UMLS CUI [2,1])
C1516879 (UMLS CUI [2,2])
C1318309 (UMLS CUI [3,1])
C1265611 (UMLS CUI [3,2])
C1524031 (UMLS CUI [3,3])
C1273604 (UMLS CUI [4])
C0027651 (UMLS CUI [5,1])
C0205092 (UMLS CUI [5,2])
C0027651 (UMLS CUI [6,1])
C0439165 (UMLS CUI [6,2])
C1318309 (UMLS CUI [6,3])
C1318309 (UMLS CUI [7,1])
C1514241 (UMLS CUI [7,2])
C1265611 (UMLS CUI [7,3])
C1273606 (UMLS CUI [7,4])
Item Group
C0680251 (UMLS CUI)
Gender | Age
Item
men less than 18 years of age
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Medically unfit Anesthesia
Item
medically unfit for anesthesia
boolean
C3841806 (UMLS CUI [1,1])
C0002903 (UMLS CUI [1,2])
Histology | Exception Adenocarcinoma
Item
histology other than adenocarcinoma
boolean
C0344441 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0001418 (UMLS CUI [2,2])
Biopsy Inclusion criteria failed
Item
biopsy does not meet inclusion criteria
boolean
C0005558 (UMLS CUI [1,1])
C1512693 (UMLS CUI [1,2])
C0231175 (UMLS CUI [1,3])
Gender Hormone manipulation | Androgen Antagonists | LHRH Agonist | 5-alpha Reductase Inhibitors
Item
men who have received any hormonal manipulation (antiandrogens; luteinizing hormone releasing hormone (lhrh) agonist; 5-alpha-reductase inhibitors) within the previous 6 months
boolean
C0079399 (UMLS CUI [1,1])
C0586971 (UMLS CUI [1,2])
C0002842 (UMLS CUI [2])
C1518041 (UMLS CUI [3])
C2936788 (UMLS CUI [4])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial